3 completed, 2 not yet recruiting, 2 unknown, 1 withdrawn. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 3, Not yet recruiting 2, Unknown 2, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow levamlodipine: new trials by email Literature Review of levamlodipine trials Research Report on levamlodipine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study Comparing Ankle Swelling Caused by Two Different Blood Pressure Medications, Levamlodipine and Amlodipine, in Post-menopausal Women With Mild High Blood Pressure. Amlodipine - Hypertension, Oedema | Phase 3 | Not yet recruiting | Zentiva, k.s. | 344 | 2026-11-30 | 2026-06-01 |
| A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients SYH9056, Levamlodipine, Valsartan - Mild-to-moderate Essential Hypertension | Phase 3 | Not yet recruiting | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 606 | 2025-01-24 | 2025-01-13 |
| Efficacy and Safety of Leningrado Association in the Treatment of Hypertension LENINGRADO association, Indapamide SR 1.5 MG, Levamlodipine 2.5/ 5 mg - Arterial Hypertension | Phase 3 | Withdrawn | EMS | 2022-04-01 | 2022-07-27 | |
| Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension AGSAVI, AGLS - Hypertension | Phase 3 | Unknown | Ahn-Gook Pharmaceuticals Co.,Ltd | 306 | 2021-02-01 | 2020-12-29 |
| Efficacy and Safety of TELMINUVO to Stage 2 Hypertension TELMINUVO Tab. (80/2.5mg), TELMINUVO Tab. (80/5mg), S-amlodipine 2.5mg - Hypertension | Phase 3 | Unknown | Chong Kun Dang Pharmaceutical | 200 | 2014-01-01 | 2013-11-14 |
| Efficacy and Safety of CKD-828 to Stage 2 Hypertension CKD-828 2.5/40mg, CKD-828 5/40mg, CKD-828 5/80mg - Hypertension | Phase 3 | Completed | Chong Kun Dang Pharmaceutical | 103 | 2012-07-01 | 2013-06-21 |
| CKD-828 S-Amlodipine Non-Responder Trial CKD-828 2.5/40mg, CKD-828 2.5/80mg, S-Amlodipine 2.5mg - Hypertension | Phase 3 | Completed | Chong Kun Dang Pharmaceutical | 187 | 2011-08-01 | 2012-11-14 |
| Anti Inflammatory Treatment of Hypertension Levamlodipine, Amlodipine - Hypertension | Phase 2 / Phase 3 | Completed | Affiliated Hospital of North Sichuan Medical College | 200 | 2010-05-01 | 2021-02-05 |
Hypertension (7) · Edema (1) · Essential Hypertension (1)
Chong Kun Dang Pharmaceutical (3) · Affiliated Hospital of North Sichuan Medical College (1) · Ahn-Gook Pharmaceuticals Co.,Ltd (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · EMS (1) · Zentiva, k.s. (1)
South Korea (3)
Chang-kyu Park, Ph.D (1) · Chul-ho Kim, Ph.D (1) · Eun-joo Jo, Ph.D (1) · Gyu-Rok Han, Ph.D (1) · Ho-Joong Yoon, Ph.D (1) · Jang-ho Bae, Ph.D (1) · Jong-jin Kim, Ph.D (1) · Sae-Joong Lim, Ph.D (1) · Sang Hyun Kim, Ph.D (1) · Tae-hoon An, Ph.D (1) · Uk-Bum Phyun, Ph.D (1) · Young-dae Kim, Ph.D (1)